Transcriptional activity of surfactant-apoproteins A1 and A2 in non small cell lung carcinomas and tumor-free lung tissues;Transkriptionelle aktivität der surfactant-apoproteine A1 und A2 in nicht kleinzelligen bronchialkarzinomen und tumorfreien lungengeweben

Pneumologie

Volumn 58, Issue 6, 2004, Pages 395-399

  Stoffers, M ^a   Goldmann, T ^a   Branscheid, D ^b   Galle, J ^a   Vollmer, E ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; MESSENGER RNA; SURFACTANT;

AMINO ACID SEQUENCE; ARTICLE; DNA SYNTHESIS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; TRANSCRIPTION, GENETIC;

EID: 3042798469     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818506     Document Type: Article

References (33)

1. Askin FB, Kuhn C. The cellular origin of pulmonary surfactant. Lab Invest 1971; 25: 260-268
2. Pattle RE. Properties, funktion and origin of the alveolar lining layer. Nature 1955; 175: 1125-1126
3. Fisher JH, Kao FT, Jones C et al. The coding sequence for the 32.000-Dalton pulmonary surfactant-associated protein A is lokated on chromosome 10 and identifies two seperate restriktion-fragment-length polymorphisms. Am J Hum Genet 1987; 40 (6): 503-511
4. Floras J, Hoover RR. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998; 1408: 312-322
5. Hoover RR, Floras J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 1998; 18: 353-362
6. Katyal SL, Singh G, Locker J. Characterization of a second human pulmonary surfactant-associated protein SP-A gene. Am J Respir Cell Mol Biol 1992; 6: 446-452
7. McCormick SM, Boggaram V, Mendelson CR. Characterization of mRNA transcripts and organisation of human SP-A1 and SP-A2 genes. Am J Physiol 1994; 266: L354-L366
8. Arias-Diaz J, Vara E, Garcia C et al. Tumor necrosis factor-α inhibits synthesis of surfactant by isolated human type II pneumocytes. Eur J Surg 1993; 159: 541-549
9. George TN, Snyder JM. Regulation of surfactant protein gene expression by retinoic acid metabolites. Pediatr Res 1997; 41 (5): 692-701
10. Hoover RR, Thomas KH, Floros J. Glucocorticoid inhibition of human SP-A1 promoter activity in NCI-H441 cells. Biochem J 1999; 340: 69-76
11. Kumar AR, Snyder JM. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glukocorticoids, and insulin. Am J Physiol 1998; 274: L177-L185
12. Mendelson R, Boggaram V. Hormonal and developmental regulation of pulmonary surfactant synthesis in fetal lung. Ballieres Clin Endocrinol Metab 1990; 8: 241-266
13. McCormick SM, Mendelson CR. Human SP-A1 and SP-A2 genes are differently regulated during development and by cAMP and glukocorticoids. Am J Physiol 1994; 266: L367-L374
14. Miakotina OL, Dekowski SA, Snyder JM. Insulin inhibits surfactant protein A and B gene expression in the H441 cell line. Biochem et Biophys Acta 1998; 1442: 60-70
15. Hamm H, Luhrs J, Guzman y Rotaeche J et al. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994; 106 (6): 1766-1770
16. Jobe AH, Ikegami M. Surfactant and acute lung injury. Proceedings of the Association of American Physicians 1998; 110 (6): 489-495
17. Johansson J, Curstedt T. Molecular structures and interactions of pulmonary surfactant components. Eur J Biochem 1997; 244: 675-693
18. Kuroki Y, Takahashi H, Chiba H et al. Surfactant proteins A and D: disease markers. Biochem et Biophys Acta 1998; 1408: 334-345
19. Mason RJ, Greene K, Voelker DR. Surfactant protein A and surfactant-protein D in health and disease. Am J Pysiol 1998; 19: L1-L13
20. McCormack FX, King Jr TE, Bucher BL et al. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 152 (2): 751-759
21. Graaf EA van de, Jansen HM, Lutter R et al. Surfactant protein A in bronchoalveolar lavage fluid. J Lab Clin Med 1992; 120(2): 252-263
22. Bhattacharjee A, Richards WG, Staunton J et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. PNAS 2001; 98 (24): 13790-13795
23. Broers JL, Jensen SM, Travis WD et al. Expression of surfactant associated protein-A and clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ-Hybridization. Lab Invest 1992; 66 (3): 337-346
24. Honda Y, Kuroki Y, Shijubo N et al. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance. Respiration 1995; 62 (2): 64-69
25. Karinch AM, deMello DE, Floros J. Effekt of genotype on the levels of surfactant protein A mRNA and on the SPA2 splice variants in adult humans. Biochem J 1997; 321: 39-47
26. Floros J, Karinch AM. Human SP-A: then and now. Am J Physiol 1995; 268: L162-L165
27. Goldmann T, Becher B, Wiedorn KH et al. Epipodite and fat cells as sites of hemoglobin synthesis in the brachiopod crustcean Daphnia magna. Histochem Cell Biol 1999; 112: 335-339
28. nd Edition. 1999
29. Clauß G, Ebner H. Grundlagen der Statistik für Psychologen, Pädagogen und Soziologen. Kap. 2 und Kap. 4. Frankfurt a.M.: Verlag Harri Deutsch, 1972
30. Betz C, Papadopoulos T, Buchwald J et al. Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: detection by reverse transcriptase-polymerase chain reaction. Cancer Res 1995; 55: 4283-4286
31. Kitamura H, Kameda Y, Ito T et al. Cytodifferentiation of atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma: immunhistochemical and ultrastructural studies. Virchows Arch 1997; 431: 415-424
32. Mori M, Tezuka F, Chiba R et al. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung. Cancer 1996; 77 (4): 665-674
33. McCormick C, Freschney R. Activity of growth factors in the IL-6 group in the differentiation of human lung adenocarcinoma. Br J Cancer 2000; 82 (4): 881-890